Clinical applicability and safety risks of puerarin in tumor adjuvant therapy based on CiteSpace and bioinformatics technology
LIU Yadi, WANG Xue, YIN Xiaoyang, LIU Zeyu, ZHANG Xiaomeng, ZHANG Bing, LIN Zhijian
Chinese Journal of Pharmacovigilance . 2023, (12): 1407 -1414 .  DOI: 10.19803/j.1672-8629.20230192